Clinical Trial Update: Adaptive Immunotherapy for Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial update for adaptive immunotherapy targeting nasopharyngeal carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Cancinoma (NPC) | Phase 3 | Status: RECRUITING